Other

Equity Method Investment, Realized Loss

Medtronic Equity Method Investment, Realized Loss increased by 450.0% to $22.00M in Q4 2025 compared to the prior quarter.

Analysis

StatementIncome Statement
SectionOther
First reportedQ3 2025
Last reportedQ3 2026Feb 24, 2026
Metric ID: other_equity_method_investment_realized_loss

Historical Data

2 periods
 Q3 '25Q3 '26
Value$4.00M$22.00M
QoQ Change—+450.0%
YoY Change—+450.0%
Range$4.00M – $22.00M
Avg YoY Growth+450.0%
Median YoY Growth+450.0%

Frequently Asked Questions

What is Medtronic's equity method investment, realized loss?
Medtronic (MDT) reported equity method investment, realized loss of $22.00M in Q4 2025.